Emotional distress may motivate patients to undergo prostate cancer surgery unnecessarily

the ONA take:

According to new analyses of a study published in the journal Psychooncology, researchers from the University at Buffalo and Roswell Park Cancer Institute in Buffalo, New York, have found emotionally distressed men diagnosed with prostate cancer may be more likely to opt for surgery.

For the study, researchers assessed 1,050 men diagnosed with clinically localized prostate cancer.

"Importantly, greater distress was associated with choosing more aggressive treatment in men with lower-risk disease among those with potentially low-risk cancer," said Heather Orom, PhD, lead investigator and an assistant professor of community health in University at Buffalo's School of Public Health and Health Professions. "These are men for whom active surveillance may be a viable option."

The initial study showed that lack of confidence in treatment decisions, worry over cancer progression, feelings of threatened masculinity, and tendencies of less optimism and resilience were associated with greater distress in newly diagnosed patients with prostate cancer.

Emotional distress may motivate patients to undergo prostate cancer surgery unnecessarily
Emotionally distressed men diagnosed with prostate cancer may be more likely to opt for surgery.
A study led by the University at Buffalo and Roswell Park Cancer Institute has identified beliefs and personality traits that are associated with higher levels of distress in newly diagnosed prostate cancer patients.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs